Berthold A. Nock
Athens, ESYE31 15341, Greece
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 67 publications
Experimental radiotherapy with the gastrin-releasing peptide receptor (GRPR) antagonist [177Lu]Lu-AU-SAR-M1 in a prostate cancer murine model using reduced-frequency dosing.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: May 27, 2026
Phase I Clinical Study with the GRPR-Antagonist [99mTc]Tc-DB8 for SPECT Imaging of Prostate Cancer: Does the Injected Peptide Mass Make a Difference?
Journal: Pharmaceutics
Published: August 28, 2025
The Impact of the Injected Mass of the Gastrin-Releasing Peptide Receptor Antagonist on Uptake in Breast Cancer: Lessons from a Phase I Trial of [99mTc]Tc-DB8.
Journal: Pharmaceutics
Published: June 10, 2025
RM2 and DB15 analogues bearing [177Lu]Lu-DOTAGA via different linkers, as radiotherapeutics: a head-to-head comparative study.
Journal: EJNMMI radiopharmacy and chemistry
Published: May 28, 2025
Combination of the amide-to-triazole substitution strategy with alternative structural modifications for the metabolic stabilization of tumor-targeting, radiolabeled peptides.
Journal: Journal of peptide science : an official publication of the European Peptide Society
Published: August 11, 2024
Bis(Disulfide)-Bridged Somatostatin-14 Analogs and Their [111In]In-Radioligands: Synthesis and Preclinical Profile.
Journal: International journal of molecular sciences
Published: December 28, 2023
Preclinical evaluation of new GRPR-antagonists with improved metabolic stability for radiotheranostic use in oncology.
Journal: EJNMMI radiopharmacy and chemistry
Published: December 15, 2023
Side-Chain Modified [99mTc]Tc-DT1 Mimics: A Comparative Study in NTS1R-Positive Models.
Journal: International journal of molecular sciences
Published: October 07, 2023
Last Updated: 09/26/2026